Crossmark

Fangchinoline demonstrates efficacy against TGEV through pAPN binding, as determined by preliminary toxicity evaluation

Published Online: 2026-04-27

Authors

Hu, Siyi

Song, Mengping

Wang, Yulu

Zhang, Jieying

Wen, Defeng

Liu, Yanan

Chen, Juncheng

Wu, Jiali

Tao, Yanfei

Wang, Xu https://orcid.org/0000-0001-6476-0509
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2023YFD1800801)
License Information

Text and Data Mining valid from 2026-04-27

Version of Record valid from 2026-04-27
More Information

Article History

Received: 22 January 2026

Accepted: 7 April 2026

First Online: 27 April 2026

Declarations

:

: This study passed the application for laboratory animal ethics review and was approved by the Animal Experimental Ethical Inspection Committee of the Laboratory Animal Centre, Huazhong Agriculture University. With the ID number: HZAUMO-2025–0381.

: Not applicable.

: The authors declare that they have no conflicts of interest.

Document is current